Zenith Drugs Limited (NSE:ZENITHDRUG)

Market Cap	1.17B
Revenue (ttm)	1.33B
Net Income (ttm)	71.61M
Shares Out	17.15M
EPS (ttm)	4.18
PE Ratio	16.27
Forward PE	n/a
Dividend	0.50 (0.74%)
Ex-Dividend Date	n/a

Volume	13,600
Average Volume	18,200
Open	68.90
Previous Close	68.90
Day's Range	68.00 - 70.25
52-Week Range	47.15 - 154.40
Beta	n/a
RSI	40.55
Earnings Date	May 29, 2025

About Zenith Drugs

Zenith Drugs Limited manufactures and trades in medicines. It provides a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets, as well as injections. The company’s products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. It operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. The company was incorporated in 1956 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1956
• Employees: 126
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ZENITHDRUG

Financial Performance

In 2023, Zenith Drugs's revenue was 1.32 billion, an increase of 14.93% compared to the previous year's 1.15 billion. Earnings were 95.93 million, an increase of 96.54%.